Company intelligence / Profile preview

Beijing Bolten

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Bolten Biotech is a Chinese medical technology company focused on the development and manufacturing of in vitro diagnostic (IVD) products. Established in 1994, the company specializes in enzyme-linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA) technologies. Its product portfolio primarily includes diagnostic kits for infectious diseases such as HIV, Hepatitis C, and Syphilis, as well as tumor markers and other clinical chemistry reagents. The company operates a GMP-certified manufacturing facility in Beijing and serves hospitals, blood centers, and clinical laboratories across China.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic KitELISAChemiluminescence
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Beijing Bolten.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Bolten.

Explore the full profile